All companies
Visit website
MAXPRO FITTECH
OperatingMaxpro FitTech, Inc.
Healthcare · Fitness · Founded 2023
Fitness technology reimagined
Post-money valuation ⓘ
$40.2M
As of Oct 2023 · from MaxPro FitTech Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$141,660
Across 1 round since 2023
Latest share price
$1.00
MaxPro FitTech Common Stock 1 offering price
Financials
FY2021–FY2025 · from SEC filings · hover any figure for its source$9.0M
−$1.8M
2021
$7.7M
−$669K
2022
$6.8M
−$312K
2023
$8.5M
−$1.2M
2024
$5.7M
−$1.1M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$8,990,304
$7,693,112
$6,776,843
$8,535,907
$5,727,493
Cost of goods sold
$4,548,987
$4,277,612
$4,727,359
$4,081,755
$2,590,603
Gross margin
49%
44%
30%
52%
55%
Net income
-$1,767,386
-$668,578
-$311,694
-$1,249,613
-$1,086,731
Taxes paid
$0
$0
$0
$0
$0
Balance sheet
Cash
$471,797
$119,854
$389,491
$351,523
$103,408
Accounts receivable
$99,670
$119,854
$82,467
$0
$75,971
Total assets
$3,331,302
$2,582,118
$2,881,928
$2,740,588
$1,963,424
Short-term debt
$3,710,807
$4,217,834
$2,151,019
$5,958,598
$6,349,865
Long-term debt
$0
$4,584,088
$3,347,101
$0
$120,098
Total liabilities
$3,710,807
$8,801,922
$5,498,120
$5,958,598
$6,469,963
Other
Headcount
—
5
5
5
5
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$40.2M
post-money
MaxPro FitTech Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $141.7K / $1.2MInvestors 86Post-money $40.2M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 3 of 3 annual reports (FY2023–FY2025)
86 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001983438Share price $1.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.